Relmada Therapeutics (RLMD) null Earnings

12NovConfirmed
Mar 20
May 20
Aug 20
Nov 20
-1.05
-0.82
-0.59
-0.36

Details

Expected EPS
-0.86
Actual EPS
-1.05
Surprise EPS
-0.19
Surprise Percent
+22.09%

Description

Relmada Therapeutics (RLMD) has reported earnings of -1.05 per share for .

0 Comments

Share your thoughts